Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease

NCT01977781 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Ocular GVHD

Interventions

DRUG: Tacrolimus
DRUG: Methylprednisolone Sodium Succinate

Sponsor

Massachusetts Eye and Ear Infirmary